Susquehanna Initiates Coverage on Given Imaging (GIVN) with a Positive
More News related to GIVN
- Given Imaging (GIVN) Announces the Degree of Impact the PillCam SB has on GI Patients, Crohn's Disease
- Three Studies Find PillCam(R) SB Enables Earlier Diagnosis and Treatment of GI Diseases Including Crohn's
- Given Imaging (GIVN) Announces Viability of PillCam Capsule in Pediatric Patients
- Given Imaging Announces RAPID(R) pH Software for Bravo(R) pH Monitoring System
- New Studies Show PillCam(R) SB to Be Clinically Valuable in Classifying and Managing Pediatric GI Symptoms
More News related to New Coverage
- Dahlman Rose Initiates Coverage on Independent Oil & Gas Stocks
- Sandler O'Neill Initiates Coverage on AON Corp. (AON) with a Hold
- Ameriprise Financial Initiates Coverage on Janus Capital (JNS) with a Buy
- BGB Securities Initiates Coverage on International Flavors & Fragrances (IFF) with a Buy
- Barrington Research Initiates Coverage on Masimo (MASI) with an Outperform
Susquehanna initiates coverage on Given Imaging (Nasdaq: GIVN) with a Positive.
Given Imaging Ltd. develops, manufactures and markets diagnostic products for disorders of the gastrointestinal tract.[SM]
Related Categories
New CoverageStocks Mentioned
+0.15Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
